Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.78ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.78ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.78ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
XBB.1.5.78NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
K.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
K.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
K.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.56ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.56NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.41ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.41NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ANUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.48.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.48.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.48.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.48.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used